A research team used flowering data from 169 rice genotypes—each with over 700,000 SNP markers—across multiple environments ...

In an era where software complexity and infrastructural dynamism challenge traditional engineering models, few professionals ...

Fresenius Medical Care’s third-party CRO, Frenova announces strategic collaboration advancing genomics-driven, precision kidney disease care: Bad Homburg Saturday, August 2, 202 ...

It’s impossible to ignore the tidal wave of excitement—and hype—surrounding generative AI. This revolutionary technology has ...

Azenta, Inc. (Nasdaq: AZTA) today announced that it has entered a collaboration with Frenova, a division of Fresenius Medical Care, and Nephronomics, a Renal Precision Medicine company, to begin ...

Cancer continues to be a substantial global health issue. By customizing prevention, diagnosis, and treatment plans depending on individual patient genetic ...

Progressive development of the human brain, a marvel of evolution, underpins our intelligence. Over millions of years, driven by many factors, the capabilities of the human brain have expanded ...

When Kara Sumner first stepped into Derby’s Early Childhood Special Education classroom as a parent volunteer, she had no ...

Bone and joint diseases pose a significant global health challenge, adversely impacting millions of individuals and exerting substantial socioeconomic ...

From nanoscale biophonics to roadkill and degraded DNA, South Australian researchers are breaking new ground — and being ...

Sound more like science fiction than actual science? Then, brace yourself because there are, at least, 15 breast cancer vaccine clinical trials in various stages in the U.S., some in phase II and III.

New research identifies NF-kappa-B-activating protein-like (NKAPL) as a potent tumor suppressor in non-small cell lung cancer ...